looking good

  1. 92 Posts.
    great opportunity here ...


    Outlook:

    Licensing - secure significant new deal

    Evamist™ - VIVUS files Evamist marketing application with FDA
    (achieved September 2006)

    Testosterone MDTS® - VIVUS starts Phase 3 trials (H1 2007)

    Contraceptive sprays - start proof of concept trials of combinations

    Testosterone MD-Lotion® - complete Phase 2 trials (H1 2007)

    New products - one successful proof of concept trial

    Fentanyl UDTS™ - open IND with FDA for Phase 2

    Cash - maintain above $10 million at all times
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.6¢ 1.7¢ 1.6¢ $6.279K 376.7K

Buyers (Bids)

No. Vol. Price($)
3 741559 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 193057 2
View Market Depth
Last trade - 16.10pm 27/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.